Topiramate as add-on drug in children, adolescents and young adults with Lennox-Gastaut syndrome: An Italian multicentric study

Epilepsy Research

Volumn 51, Issue 1-2, 2002, Pages 147-153

  Coppola, Giangennaro ^a   Caliendo, Graziella ^a   Veggiotti, Pierangelo ^b   Romeo, Antonino ^c   Tortorella, Gaetano ^d   De Marco, Pasquale ^e   Pascotto, Antonio ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^c FATEBENEFRATELLI HOSPITAL   (Italy)

^d UNIVERSITY OF MESSINA   (Italy)

^e SANTA CHIARA HOSPITAL   (Italy)

Author keywords

Adolescents and young adults; Children; Lennox Gastaut syndrome; Therapy; Topiramate

Indexed keywords

TOPIRAMATE;

ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOSE CALCULATION; DROP ATTACK; DROWSINESS; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; ITALY; LENNOX GASTAUT SYNDROME; MALE; NERVOUSNESS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEIZURE; TITRIMETRY; WEIGHT REDUCTION;

ADOLESCENT; ADULT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; FRUCTOSE; HUMANS; ITALY; MALE; TREATMENT OUTCOME;

EID: 0036752216     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(02)00103-1     Document Type: Article

References (30)

1. Bourgeois B.F.D. Pharmacokinetics and pharmacodynamics of topiramate. J. Child Neurol. 15:2000;S27-S30.
2. Brunet O., Lézine I. Le développement psychologique de la première enfance. 1951;Presse Universitaire de France, Paris.
3. Commission on classification and terminology of the International League against Epilepsy, 1981. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22, 489-501.
4. Commission on Classification and Terminology of the International League against Epilepsy, 1989. Proposal for revised classification of epilepsies syndromes. Epilepsia 30, 389-399.
5. Coppola G., Caliendo G., Terracciano M.M., Buono S., Pellegrino L., Pascotto A. Topiramate in refractory partial-onset seizures in children, adolescents and young adults: a multicentric open trial. Epilepsy Res. 43:(3):2001;255-260.
6. Dooley J.M., Camfield P.R., Smith E., Langevin P., Ronen G. Topiramate in intractable childhood onset epilepsy-a cautionary note. Can. J. Neurol. Sci. 26:1999;271-273.
7. Topiramate YP Study Group, Elterman R.D., Glauser T.A., Wyllie E., Reife R., Wu S.C., Pledger G. A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Neurology. 52:1999;1338-1344.
8. Frost M., Gates J., Helmers L.J., Wheless J.W., Levisohn P., Tardo C., Conry J.A. Vagus nerve stimulation in children with refractory seizures associated with Lennox-Gastaut syndrome. Epilepsia. 42:2001;1148-1152.
9. Glauser T.A., Clark P.O., Strawsburg R. A pilot study of topiramate in the treatment of infantile spasms. Epilepsia. 39:1998;1324-1328.
10. Glauser T.A. Topiramate in the catastrophic epilepsies of childhood. J. Child Neurol. 15:(Suppl. 1):2000;S14-S21.
11. The Topiramate YL Study Group, Glauser T.A., Levishon P.M., Ritter F., Sachdeo R.C. Topiramte in Lennox-Gastaut syndrome: open-label treatment of patients completing a randomized controlled trial. Epilepsia. 41:(Suppl. 1):2000;S86-S90.
12. Guerreiro M.M., Manreza M.L., Scotoni A.E., Silva E.A., Guerreiro C.A., Sonza E.A., Ferriera V., Reed V.C., Diament A., Trefiglio R., Chiu H., Bacaltchuk J. A pilot study of topiramate in children with Lenox-Gastaut syndrome. Arq. Neuropsiquiatr. 57:(2A):1999;167-175.
13. Guerrini R., Belmonte A., Genton P. Antiepileptic drug-induced worsening of seizures in children. Epilepsia. 39:(3):1998;S2-S10.
14. Kugler S., Mandelbaum D., Traeger E. Broad-spectrum efficacy of topiramate in children. Epilepsia. 39:(Suppl. 6):1998;164-165.
15. Levinsohn P., Lambert-Kerzner A. Safety and tolerability of topiramate in pediatric epilepsy. Epilepsia. 39:(Suppl. 6):1998;165.
16. Mohamed K., Appleton R., Rosenbloom L. Efficacy and tolerability of topiramate in childhood and adolescent epilepsy: a clinical experience. Seizure. 9:2000;137-141.
17. Moreland E.C., Griesemer D.A., Holden K.R. Topiramate for intractable childhood epilepsy. Seizure. 8:1999;38-40.
18. Nieto-Barrera M., Candau R., Nieto-Jimenez M., Correa A., Ruiz del Portal L. Topiramate in the treatment of severe myoclonic epilepsy in infancy. Seizure. 9:2000;590-594.
19. Perucca E., Gram L., Avanzini G., Dulac O. Antiepileptic drugs as a cause of worsening seizures. Epilepsia. 39:(1):1998;5-17.
20. Rosenfeld W.E., Liao S., Kramer L.D., et al. Comparison of the steady-state pharmacokinetics of topiramate and valproate in patients with epilepsy during monotherapy and concomitant therapy. Epilepsia. 38:1997;324-333.
21. Sachdeo R.C., Sachdeo S.K., Walker S.A., et al. Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy. Epilepsia. 37:1996;774-780.
22. The Topiramate YL Study Group, Sachdeo R.C., Glauser T.A., Ritter F., Reife R., Lim P., Pledger G. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Neurology. 52:1999;1882-1887.
23. Schmidt D., Bourgeois B. A risk benefit assessment of therapies for Lennox-Gastaut syndrome. Drug Saf. 22:2000;467-477.
24. Terman L.M., Merrill M. Stanford-Binet Intelligence Scale: Manual for the Third Revision, Form L-M. 1960;Houghton Mifflin, Boston.
25. Thio L., Bourgeois B., Arnold S. Postmarketing multicenter open-study of topiramate in children. Epilepsia. 39:(Suppl. 6):1998;54-55.
26. Uldall P., Buchholt J.M. Clinical experience with topiramate in children with intractable epilepsy. Eur. J. Paediatr. Neurol. 3:1999;105-111.
27. Vitale S., Bicknese A., Andriola M. Efficacy and safety of topiramate in pediatric epilepsy syndromes. Epilepsia. 39:(Suppl. 6):1998;165.
28. Yeung S., Ferrie C.D., Murdoch-Eaton D.G., Livingston J.H. Topiramate for drug-resistant epilepsies. Eur. J. Paediatr. Neurol. 4:2000;31-33.
29. Wheless J.W. Use of topiramate in childhood generalized seizure disorders. J. Child Neurol. 15:(Suppl. 1):2000;S7-S13.
30. Zhang X., Velumian A.A., Jones O.T., Carlen P.L. Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramate. Epilepsia. 41:2000;S52-S60.